Eligibility depends on factors such as medical history, current medications, laboratory findings, and overall health profile
GLP-1s have been shown to reduce peoples desire for alcohol, cannabis, nicotine, and opioids
The trial achieved its primary endpoint by demonstrating a statistically significant and superior weight loss at week 72 with semaglutide 7.2 mg versus placebo
Keeping cold protein sources like Greek yogurt, cottage cheese, and protein shakes available ensures adequate nutrition during periods when cooking feels unappealing
Diabetes 49 , 17511760, doi:10.2337/diabetes.49.11.1751 (2000)
Tirzepatide is a dual GIP/GLP-1 receptor agonist, a peptide that works on two key incretin pathways in the body to regulate blood sugar, reduce appetite, and promote meaningful weight loss